Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|18|1818-1869

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.18, 2016-06, pp. : 1818-1869

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Development of Radioligands for Imaging α7 Nicotinic Acetylcholine Receptors in the Brain

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 15, 2010-10 ,pp. : 1544-1557

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Radioligands for Imaging of Brain Norepinephrine Transporters In Vivo with Positron Emission Tomography

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 18, 2007-01 ,pp. : 1806-1816

Bentham Science Publishers

Access to resources Recommend Favorite

PET and SPECT Imaging of the Opioid System: Receptors, Radioligands and Avenues for Drug Discovery and Development

By  

Current Pharmaceutical Design, Vol. 13, Iss. 1, 2007-01 ,pp. : 33-49

Bentham Science Publishers

Access to resources Recommend Favorite

The Quest for Eldorado: Development of Radioligands for In Vivo Imaging of Nicotinic Acetylcholine Receptors in Human Brain

By  

Current Pharmaceutical Design, Vol. 12, Iss. 30, 2006-10 ,pp. : 3877-3900

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Radioligands for In Vivo Imaging of Type 1 Cannabinoid Receptors (CB1) in Human Brain

By  

Current Pharmaceutical Design, Vol. 14, Iss. 31, 2008-11 ,pp. : 3363-3383

Bentham Science Publishers

Access to resources Recommend Favorite